Shree Ganesh Remedies Stock Screener | Share Price & Fundamental Analysis
SGRL
Pharmaceuticals
Screen Shree Ganesh Remedies share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹461.95
▲
7.65 (1.68%)
Market Cap
₹584.03 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
3.60
EPS (TTM)
₹17.96
Dividend Yield
-
Debt to Equity
0.28
52W High
₹893.20
52W Low
₹426.50
Operating Margin
40.00%
Profit Margin
25.93%
Revenue (TTM)
₹27.00
EBITDA
₹12.00
Net Income
₹7.00
Total Assets
₹192.00
Total Equity
₹145.00
Shree Ganesh Remedies Share Price History - Stock Screener Chart
Screen SGRL historical share price movements with interactive charts. Analyze price trends and patterns.
Shree Ganesh Remedies Company Profile - Fundamental Screener
Screen Shree Ganesh Remedies company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SGRL shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE414Y01015
Shree Ganesh Remedies Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen SGRL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2020 | 2019 |
|---|---|---|---|---|
| Assets | ||||
| Total Assets | 192 | 171 | 55 | 41 |
| Current Assets | 78 | 70 | 34 | 26 |
| Fixed Assets | 95 | 81 | 20 | 15 |
| Liabilities | ||||
| Total Liabilities | 192 | 171 | 55 | 41 |
| Current Liabilities | 31 | 30 | 3 | 1 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||
| Total Equity | 145 | 122 | 42 | 34 |
| Share Capital | 13 | 13 | 9 | 9 |
| Reserves & Surplus | 132 | 109 | 33 | 25 |
Screen SGRL income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2021-Mar | 2021-Jun | 2021-Sept | 2021-Dec | 2020-Jun | 2020-Sept | 2020-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 27 | 25 | 31 | 39 | 25 | 33 | 28 | 16 | 14 | 17 | 22 | 10 | 12 | 14 |
| Expenses | 15 | 17 | 21 | 20 | 17 | 21 | 17 | 10 | 10 | 13 | 15 | 8 | 7 | 10 |
| EBITDA | 12 | 8 | 10 | 18 | 9 | 12 | 11 | 5 | 4 | 5 | 7 | 2 | 5 | 4 |
| Operating Profit % | 40.00% | 30.00% | 32.00% | 45.00% | 33.00% | 35.00% | 37.00% | 33.00% | 24.00% | 26.00% | 27.00% | 12.00% | 36.00% | 24.00% |
| Depreciation | 2 | 2 | 3 | 2 | 2 | 2 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| Interest | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 9 | 5 | 7 | 16 | 6 | 9 | 8 | 4 | 3 | 4 | 6 | 1 | 4 | 4 |
| Tax | 2 | 1 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Net Profit | 7 | 4 | 5 | 13 | 5 | 6 | 5 | 3 | 2 | 3 | 4 | 1 | 3 | 3 |
| EPS | 5.13 | 2.68 | 3.86 | 10.01 | 3.62 | 4.97 | 4.22 | 3.03 | 4.68 | 3.02 | 3.50 | 0.85 | 6.18 | 2.31 |
Shree Ganesh Remedies Cash Flow Screener - Liquidity Fundamentals
Screen SGRL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2020-March | 2019-March |
|---|---|---|---|---|
| Operating Activities | 31 | 31 | 5 | -5 |
| Investing Activities | -36 | -33 | -3 | 0 |
| Financing Activities | -1 | 10 | -1 | 0 |
| Net Cash Flow | -6 | 7 | 1 | -6 |
Screen SGRL shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Feb |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 72.80% | 72.80% | 72.80% | 69.33% | 69.33% | 70.50% | 72.80% | 69.32% |
| FII Holding | 0.01% | 0.01% | 0.01% | 0.00% | 0.01% | 0.01% | 0.01% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 24.89% | 24.87% | 24.92% | 28.14% | 28.51% | 27.23% | 24.88% | 26.37% |
| Other Holding | 2.31% | 2.32% | 2.27% | 2.53% | 2.15% | 2.26% | 2.32% | 4.31% |
| Shareholder Count | 8,978 | 9,166 | 8,752 | 7,049 | 7,186 | 8,508 | 8,695 | 6,771 |
Shree Ganesh Remedies Dividend Screener - Share Yield Analysis
Screen SGRL dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.50 | 0.07% |
| 2023-March | ₹0.30 | 0.04% |
| 2022-March | ₹0.50 | 0.20% |
| 2021-March | ₹1.75 | 0.59% |
| 2020-March | ₹1.50 | 0.54% |
| 2019-March | ₹1.25 | 2.32% |
| 2018-March | ₹1.00 | 2.49% |
| 2017-March | ₹0.00 | 0.00% |
| 2016-March | ₹0.00 | 0.00% |
Shree Ganesh Remedies Index Membership - Market Screener Classification
Screen SGRL by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Shree Ganesh Remedies Market Events Screener - Corporate Actions
Screen SGRL market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -5.12% | ||
| Dividend | ₹ 1.75 /share | 24.70% | ||
| Dividend | ₹ 0.50 /share | -19.88% | ||
| Annual General Meeting | NA | 4.64% | ||
| Dividend | ₹ 0.50 /share | 52.75% | ||
| 2025-11-07 | 2025-11-07 | Quarterly Result Announcement | NA | -0.77% |
| 2025-08-01 | 2025-08-01 | Quarterly Result Announcement | NA | -3.35% |
| 2025-05-19 | 2025-05-19 | Quarterly Result Announcement | NA | 3.44% |
| 2025-02-05 | 2025-02-05 | Quarterly Result Announcement | NA | 33.42% |
| 2024-10-29 | 2024-10-29 | Quarterly Result Announcement | NA | -1.34% |
| 2023-02-03 | 2023-02-03 | Rights | 7:100 | -2.38% |
| 2021-11-01 | 2021-11-02 | Bonus | 1:5 | 13.55% |
Shree Ganesh Remedies Competitors Screener - Peer Comparison
Screen SGRL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 412,734 | 39.30 | 54,729 | 9.71% | 10,980 | 39.06 |
| Divis Laboratories | 168,851 | 68.25 | 9,712 | 18.67% | 2,191 | 44.96 |
| Torrent Pharmaceuticals | 129,357 | 59.98 | 11,539 | 6.99% | 1,911 | 59.35 |
| Cipla | 120,557 | 22.21 | 28,410 | 7.12% | 5,291 | 42.76 |
| Dr Reddys Laboratories | 105,645 | 18.46 | 33,741 | 16.73% | 5,725 | 49.97 |
| Lupin | 95,023 | 21.85 | 22,910 | 13.74% | 3,306 | 50.10 |
| Zydus Life Science | 90,707 | 18.09 | 23,511 | 18.55% | 4,615 | 34.06 |
| Mankind Pharma | 88,846 | 50.78 | 12,744 | 20.90% | 2,007 | 40.67 |
| Aurobindo Pharma | 68,901 | 20.36 | 32,346 | 9.43% | 3,484 | 46.33 |
| Alkem Laboratories | 65,390 | 27.28 | 13,458 | 3.70% | 2,216 | 37.45 |
Shree Ganesh Remedies Company Announcements - News Screener
Screen SGRL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-03 | Closure of Trading Window | View |
| 2025-11-16 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2025-11-12 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2025-11-08 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-07 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-11-07 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-11-07 | Announcement under Regulation 30 (LODR)-Resignation of Director | View |
| 2025-11-07 | Financial Results For Quarter And Half Year Ended September 30 2025 | View |
| 2025-11-07 | Board Meeting Outcome for Outcome Of Board Meeting | View |
| 2025-11-07 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-03 | Board Meeting Intimation for The Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025 | View |
| 2025-10-10 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-09-25 | Closure of Trading Window | View |
| 2025-09-15 | Announcement under Regulation 30 (LODR)-Resignation of Director | View |
| 2025-09-15 | Board Meeting Outcome for Outcome Of Board Meeting | View |
| 2025-09-09 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-09 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-08-19 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-08-18 | Notice Of 30Th Annual General Meeting On September 09 2025 | View |
| 2025-08-18 | Reg. 34 (1) Annual Report. | View |